... of biomanufacturing, clinical development programs, and pre-clinical research, will enhance the company's capabilities in cell and gene therapy.
https://www.google.com/url?rct=j&sa=t&url=http://www.proactiveinvestors.com/companies/news/953526/avalon-globocare-says-senlangbio-will-enhance-its-capabilities-in-cell-and-gene-therapy-953526.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEQUhsO5wtPMDz--rZD2BoAieUHHA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.